Home/Filings/4/0000899243-19-002639
4//SEC Filing

McDonough John 4

Accession 0000899243-19-002639

CIK 0001492674other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:54 PM ET

Size

14.9 KB

Accession

0000899243-19-002639

Insider Transaction Report

Form 4
Period: 2017-11-30
McDonough John
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2017-11-3047,4230 total
    Common Stock (47,423 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2018-11-3047,4220 total
    Common Stock (47,422 underlying)
  • Exercise/Conversion

    Common Stock

    2017-11-30+47,423406,604 total
  • Exercise/Conversion

    Common Stock

    2018-11-30+47,422454,026 total
  • Sale

    Common Stock

    2019-01-31$3.35/sh4,895$16,398449,131 total
  • Sale

    Common Stock

    2019-02-01$3.47/sh9,443$32,767439,688 total
Footnotes (5)
  • [F1]Each restricted stock units ("RSU's") represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]Includes 567 shares acquired under the Issuer's employee stock purchase plan on November 15, 2018.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.32 to $3.39. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $3.34 to $3.55. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]On November 30, 2016 the reporting person was granted 94,845 RSU's that vested in two equal annual installments beginning on November 30, 2017.

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001615937

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:54 PM ET
Size
14.9 KB